Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Pfizer Inc (PFE)

52.54   1 (1.94%) 01-26 00:30
Open: 51.36 Pre. Close: 51.54
High: 52.835 Low: 51.24
Volume: 40,499,373 Market Cap: 294,900M
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; Arvinas, Inc.; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 52.906 - 53.202 53.202 - 53.473
Low: 50.46 - 50.846 50.846 - 51.201
Close: 51.974 - 52.54 52.54 - 53.059

Technical analysis

as of: 2022-01-25 4:26:21 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 66.77     One year: 72.08
Support: Support1: 49.81    Support2: 41.45
Resistance: Resistance1: 57.17    Resistance2: 61.71
Pivot: 54.62
Moving Average: MA(5): 52.89     MA(20): 55.45
MA(100): 49.45     MA(250): 43.40
MACD: MACD(12,26): -0.70     Signal(9): -0.08
Stochastic oscillator: %K(14,3): 20.01     %D(3): 13.29
RSI: RSI(14): 41.06
52-week: High: 61.71  Low: 33.36  Change(%): 46.4
Average Vol(K): 3-Month: 45354  10-Days: 35346

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PFE has closed above bottom band by 15.0%. Bollinger Bands are 2.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 25 Jan 2022
Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine - Reuters

Tue, 25 Jan 2022
Is Pfizer a buy on the strength of its new COVID-19 pill? - Seeking Alpha

Tue, 25 Jan 2022
Pfizer Inc. (PFE) is down -4.95% in a Week, Should You Buy? - InvestorsObserver

Mon, 24 Jan 2022
PFE Stock Price: Pfizer Inc keeps falling despite soaring covid cases - FXStreet

Mon, 24 Jan 2022
Should You Invest in Pfizer in 2022? - Motley Fool

Sun, 23 Jan 2022
Pfizer Stock (PFE): Why The Price Fell Today - Pulse 2.0

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers—General
Shares Out. (M) 5,610
Shares Float (M) 5,610
% Held by Insiders 0.04
% Held by Institutions 67.45
Shares Short (K) 58,640
Shares Short P. Month (K) 63,560

Stock Financials

EPS 3.500
EPS Est This Year 2.560
EPS Est Next Year 2.760
Book Value (p.s.) 13.490
Profit Margin 28.68
Operating Margin 32.14
Return on Assets (ttm) 7.8
Return on Equity (ttm) 27.8
Qtrly Rev. Growth 134.4
Gross Profit (p.s.) 5.941
Sales Per Share 12.360
EBITDA (p.s.) 4.868
Qtrly Earnings Growth 454.50
Operating Cash Flow (M) 32,290
Levered Free Cash Flow (M) 42,430

Stock Valuations

PE Ratio 15.01
PEG Ratio
Price to Book value 3.89
Price to Sales 4.25
Price to Cash Flow

Stock Dividends

Dividend 1.550
Forward Dividend 1.600
Dividend Yield 0.03
Dividend Pay Date 2022-03-03
Ex-Dividend Date 2022-01-26
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.